Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 03, 2015
Cytovance Biologics, Inc. announced that it has entered into a Development and Manufacturing Agreement for the production of Phase III batches of a universal flu vaccine, M-001, with BiondVax Pharmaceuticals Ltd. (TASE: BVXV) (NASDAQ: BVXV), a ...
read more
Wednesday, November 25, 2020
Bionova Scientific announced it has secured its first client commitment for GMP clinical supply.
read more
Wednesday, September 23, 2020
BioNTech announced the signing of a share purchase agreement with Novartis AG, Basel / Switzerland to acquire their GMP certified manufacturing facility in Marburg, Germany.
read more
Monday, September 21, 2020
BioNTech will receive a grant by the German Federal Ministry of Education and Research to support the accelerated development of SARS-CoV-2 vaccines.
read more
Carolyn Finkle, Vice President, Global Regulatory Consulting at Catalent Pharma Solutions will present a webinar on “Biosimilars: Current Regulatory Environment and Development and Manufacturing Considerations” for the Pharmaceutical Education and ...
read more
BioStem Life Sciences has received it’s ISBT 128 Registration from the ICCBBA.
read more
BioStem Life Sciences announced the buildout of a brand new R&D lab.
read more
Tuesday, January 15, 2013
Biotest Pharmaceuticals Corp. (BPC), a wholly owned U.S. subsidiary of Biotest AG (Dreieich, Germany), today announced it has entered into a strategic long-term manufacturing, supply, and license agreement with ADMA Biologics,Inc.(ADMA).
read more
BioVaxys announced that its bioproduction partner Bio Elpida of Lyon, France, has initiated the construction of a new Good Manufacturing Practice ("GMP") cleanroom facility needed for producing the clinical supply of BVX-0918A, BioVaxys' ovarian ...
read more
Saturday, September 25, 2021
ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing and BIOVECTRA, a CDMO specializing in clinical-to-commercial scale production of high-quality regulated Biologics, Active Pharmaceutical Ingredients, and...
read more
BioVectra announced a five-year, $144.6 million (CAD) expansion project to enhance its Biopharmaceutical capabilities in both Charlottetown, Prince Edward Island and Windsor, Nova Scotia.
read more
Thursday, November 18, 2021
BIOVECTRA has announced plans for the development of a state-of-the-art facility specializing in the production and manufacturing of mRNA vaccines and therapeutics – one of the first of its kind in Canada.
read more
BIOVECTRA has broken ground on a cutting-edge facility that will manufacture mRNA vaccines and therapeutics starting in 2023.
read more
Thursday, December 14, 2017
BioVectra announced a long-term supply agreement with Keryx Biopharmaceuticals to manufacture Ferric Citrate.
read more
Thursday, November 18, 2021
BiVictriX Therapeutics plc, an emerging biotechnology company applying a novel approach to develop next generation cancer therapies using insights derived from frontline clinical experience is pleased to announce a collaboration to manufacture ...
read more